Eitan Yaniv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Eitan Yaniv has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Jacob Shvero
Nose and Sinus Institute, Department of Otorhinolaryngology, Tel Aviv University, Tel Aviv, Israel
4 shared publicationsTuvia Hadar
Nose and Sinus Institute, Department of Otorhinolaryngology, Tel Aviv University, Tel Aviv, Israel
4 shared publicationsB. Nageris
1 shared publicationBen Nageris
Nose and Sinus Institute, Department of Otorhinolaryngology, Tel Aviv University, Tel Aviv, Israel
1 shared publication- Dan Yaniv
Department of Otolaryngology-Head and Neck Surgery, Rabin Medical Center, Petach Tikva, Israel
1 shared publication Eyal Raveh
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
1 shared publication
Latest Publications
- 5 October 2016
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 7 (2) , 211-214
Repair of caudal septal deviation: the fishing line technique
Background Repair of caudal septal deviation using currently described methods is challenging technically. The aim of this work is to describe a novel and simple technique for the treatment of caudal septal deviations that protects the nasal tip, by fixating of cartilage to the columella. Methods All patients with caudal septal deviation operated on between June 2008 to November 2013 in 2 major medical centers were operated using the “fishing line technique.” Patient satisfaction was recorded by a standard questionnaire (16‐item Sino‐Nasal Outcome Test [SNOT‐16]), before and after surgery. The fishing line technique was performed in 63 patients with a severe caudal septal deviation of which 14 also had rhinoplasty. A mucoperichondrial flap was elevated on either side of the damaged septal cartilage. The cartilage was excised and remodeled into a straight sheet, and then repositioned between the mucoperichondrial flaps, and fixed to the septal columella. Results Mean age of the study group was 36 years. Follow‐up ranged from 24 to 70 months. At the last follow‐up, the septum was straight in all cases, with no deviation from the nostrils to the choana. Good airway was found in 53 patients. Eight patients had partial turbinate hypertrophy with an impaired airway, and 2 had severe turbinate hypertrophy. SNOT‐16 mean score improved from 27 to 10 (p < 0.001). All patients were satisfied with the aesthetic outcome. Conclusion The fishing‐line technique for severe caudal septum deviations is easy to perform and yields satisfactory anatomic and aesthetic results.
- 5 October 2016
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 7 (2) , 211-214
Repair of caudal septal deviation: the fishing line technique
Background Repair of caudal septal deviation using currently described methods is challenging technically. The aim of this work is to describe a novel and simple technique for the treatment of caudal septal deviations that protects the nasal tip, by fixating of cartilage to the columella. Methods All patients with caudal septal deviation operated on between June 2008 to November 2013 in 2 major medical centers were operated using the “fishing line technique.” Patient satisfaction was recorded by a standard questionnaire (16‐item Sino‐Nasal Outcome Test [SNOT‐16]), before and after surgery. The fishing line technique was performed in 63 patients with a severe caudal septal deviation of which 14 also had rhinoplasty. A mucoperichondrial flap was elevated on either side of the damaged septal cartilage. The cartilage was excised and remodeled into a straight sheet, and then repositioned between the mucoperichondrial flaps, and fixed to the septal columella. Results Mean age of the study group was 36 years. Follow‐up ranged from 24 to 70 months. At the last follow‐up, the septum was straight in all cases, with no deviation from the nostrils to the choana. Good airway was found in 53 patients. Eight patients had partial turbinate hypertrophy with an impaired airway, and 2 had severe turbinate hypertrophy. SNOT‐16 mean score improved from 27 to 10 (p < 0.001). All patients were satisfied with the aesthetic outcome. Conclusion The fishing‐line technique for severe caudal septum deviations is easy to perform and yields satisfactory anatomic and aesthetic results.
- 1 June 2011
- Published by Stichting Nase in Rhinology journal
- Vol. 49 (2) , 214-216
Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial
Hereditary hemorrhagic telangiectasia (HHT) is associated with recurrent epistaxis in 90% of the cases. Good response to hormone treatment has been documented, although its use remains controversial. The aim of this study was to examine the efficacy of an anti-estrogenic agent, tamoxifen, in the treatment of HHT-associated epistaxis. Out of 46 patients with diagnosis of epistaxis due to HHT who started treatment with tamoxifen 20 mg/d, 38 patients completed a mean of 23.4 months of treatment. All patients filled out a self-assessment questionnaire of rhinologic Quality of Life and epistaxis grading scale. The bleeding score and the Quality of Life score improved. Hemoglobin concentration also improved. None of the patients needed blood transfusions during the treatment period. Only one patient had minor side effects of the drug. Tamoxifen appears to be an effective agent for the treatment of epistaxis due to HHT.
- 1 June 2011
- Published by Stichting Nase in Rhinology journal
- Vol. 49 (2) , 214-216
Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial
Hereditary hemorrhagic telangiectasia (HHT) is associated with recurrent epistaxis in 90% of the cases. Good response to hormone treatment has been documented, although its use remains controversial. The aim of this study was to examine the efficacy of an anti-estrogenic agent, tamoxifen, in the treatment of HHT-associated epistaxis. Out of 46 patients with diagnosis of epistaxis due to HHT who started treatment with tamoxifen 20 mg/d, 38 patients completed a mean of 23.4 months of treatment. All patients filled out a self-assessment questionnaire of rhinologic Quality of Life and epistaxis grading scale. The bleeding score and the Quality of Life score improved. Hemoglobin concentration also improved. None of the patients needed blood transfusions during the treatment period. Only one patient had minor side effects of the drug. Tamoxifen appears to be an effective agent for the treatment of epistaxis due to HHT.
- 1 September 2009
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 23 (5) , 527-530
KTP/532 YAG Laser Treatment for Allergic Rhinitis
Background: The purpose of this study was to investigate the efficacy of the KTP/532 YAG laser to reduce nasal congestion and discharge in patients with allergic rhinitis. Methods: Forty-eight patients with symptoms of allergic rhinitis were treated with the KTP/532 laser. All had positive skin tests for common allergens. Treatments were provided on an ambulatory basis in one to three sessions under local anesthesia with lidocaine nose spray. Outcome was determined by daily symptom reports and regular endoscopy examination and interviews for 12 months. Results: Treatment was very well tolerated. There were no major side effects. At examination after 1 year, nasal obstruction was improved in 69% and nasal discharge in 40% of cases. Conclusion: The KTP/532 YAG laser is effective for the treatment of nasal obstruction and discharge. Comparison with other techniques showed it to be the most effective in reducing nasal discharge. It can be done as an office procedure and does not damage the nasal mucous membrane. The KTP/532 YAG laser is effective as an additional treatment for patients refractory to medication.
- 1 September 2009
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 23 (5) , 527-530
KTP/532 YAG Laser Treatment for Allergic Rhinitis
Background: The purpose of this study was to investigate the efficacy of the KTP/532 YAG laser to reduce nasal congestion and discharge in patients with allergic rhinitis. Methods: Forty-eight patients with symptoms of allergic rhinitis were treated with the KTP/532 laser. All had positive skin tests for common allergens. Treatments were provided on an ambulatory basis in one to three sessions under local anesthesia with lidocaine nose spray. Outcome was determined by daily symptom reports and regular endoscopy examination and interviews for 12 months. Results: Treatment was very well tolerated. There were no major side effects. At examination after 1 year, nasal obstruction was improved in 69% and nasal discharge in 40% of cases. Conclusion: The KTP/532 YAG laser is effective for the treatment of nasal obstruction and discharge. Comparison with other techniques showed it to be the most effective in reducing nasal discharge. It can be done as an office procedure and does not damage the nasal mucous membrane. The KTP/532 YAG laser is effective as an additional treatment for patients refractory to medication.
- 21 January 2009
- Published by Wiley in The Laryngoscope
- Vol. 119 (2) , 284-288
Antiestrogen therapy for hereditary hemorrhagic telangiectasia: A double‐blind placebo‐controlled clinical trial
Objectives/Hypothesis: Hereditary hemorrhagic telangiectasia (HHT) is associated with recurrent epistaxis in 90% of cases. Good response to hormone treatment has been documented, although its use remains controversial. The aim of this study was to examine the efficacy of an antiestrogenic agent, Tamoxifen, in the treatment of HHT‐associated epistaxis.Methods: Twenty‐five patients (11 men, 14 women; mean age 51 years) with a diagnosis of epistaxis due to HHT were randomly assigned to receive treatment with oral tamoxifen 20 mg/d or placebo for 6 months. Follow‐up consisted of physical examination and once‐monthly blood tests.Results: The groups were similar in age and sex distribution. Of the 21 participants who completed the trial, alleviation of the epistaxis was noted in 9 of 10 tamoxifen‐treated patients and 3 of 11 placebo‐treated patients (including 2 with only temporary improvement). The difference between the groups at the trial end point was significant for both frequency (P= .01) and severity (P= .049) of the disease. Hemoglobin concentration rose in 4 tamoxifen‐treated patients and decreased in 5 controls.Conclusions: Tamoxifen appears to be an effective agent for the treatment of epistaxis due to HHT. Laryngoscope, 2009
- 21 January 2009
- Published by Wiley in The Laryngoscope
- Vol. 119 (2) , 284-288
Antiestrogen therapy for hereditary hemorrhagic telangiectasia: A double‐blind placebo‐controlled clinical trial
Objectives/Hypothesis: Hereditary hemorrhagic telangiectasia (HHT) is associated with recurrent epistaxis in 90% of cases. Good response to hormone treatment has been documented, although its use remains controversial. The aim of this study was to examine the efficacy of an antiestrogenic agent, Tamoxifen, in the treatment of HHT‐associated epistaxis.Methods: Twenty‐five patients (11 men, 14 women; mean age 51 years) with a diagnosis of epistaxis due to HHT were randomly assigned to receive treatment with oral tamoxifen 20 mg/d or placebo for 6 months. Follow‐up consisted of physical examination and once‐monthly blood tests.Results: The groups were similar in age and sex distribution. Of the 21 participants who completed the trial, alleviation of the epistaxis was noted in 9 of 10 tamoxifen‐treated patients and 3 of 11 placebo‐treated patients (including 2 with only temporary improvement). The difference between the groups at the trial end point was significant for both frequency (P= .01) and severity (P= .049) of the disease. Hemoglobin concentration rose in 4 tamoxifen‐treated patients and decreased in 5 controls.Conclusions: Tamoxifen appears to be an effective agent for the treatment of epistaxis due to HHT. Laryngoscope, 2009
- 1 March 2007
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 71 (3) , 457-462
Endoscopic transnasal repair of choanal atresia
- 1 March 2007
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 71 (3) , 457-462
Endoscopic transnasal repair of choanal atresia
- 1 March 2006
- Published by SAGE Publications in American Journal of Rhinology
- Vol. 20 (2) , 227-229
Hemostatic Effect of Tranexamic Acid in Elective Nasal Surgery
Background: Bleeding is the most frequent complication of nasal surgery. The aim of this prospective study was to evaluate the effectiveness of tranexamic acid (TA), an antifibrinolytic agent, in reducing bleeding during and after nasal surgery. Methods: The study sample included 400 patients aged 18–60 years who underwent combination functional endoscopic sinus surgery with septoplasty and conchotomy. Two hundred patients were not given a hemostatic agent (control group) and 200 patients were administered 1 g of oral TA three times daily starting 2 hours before surgery, for 5 days. Bleeding was monitored during surgery and for 2 weeks postoperatively. Results: Patients given oral TA showed significantly less operative and postoperative bleeding compared with controls. No patients required additional packing, compared with five patients in the control group. Adverse reactions to TA were minimal, and they disappeared when the treatment stopped. Conclusion: TA is a safe and effective drug for the reduction of bleeding in nasal surgery. It may be recommended for routine use.
- 1 March 2006
- Published by SAGE Publications in American Journal of Rhinology
- Vol. 20 (2) , 227-229
Hemostatic Effect of Tranexamic Acid in Elective Nasal Surgery
Background: Bleeding is the most frequent complication of nasal surgery. The aim of this prospective study was to evaluate the effectiveness of tranexamic acid (TA), an antifibrinolytic agent, in reducing bleeding during and after nasal surgery. Methods: The study sample included 400 patients aged 18–60 years who underwent combination functional endoscopic sinus surgery with septoplasty and conchotomy. Two hundred patients were not given a hemostatic agent (control group) and 200 patients were administered 1 g of oral TA three times daily starting 2 hours before surgery, for 5 days. Bleeding was monitored during surgery and for 2 weeks postoperatively. Results: Patients given oral TA showed significantly less operative and postoperative bleeding compared with controls. No patients required additional packing, compared with five patients in the control group. Adverse reactions to TA were minimal, and they disappeared when the treatment stopped. Conclusion: TA is a safe and effective drug for the reduction of bleeding in nasal surgery. It may be recommended for routine use.